The opportunity
We are seeking an innovative Translational and Precision Medicine Disease Area Head to drive the growth of our Immuno-oncology portfolio. This role will shape the strategic direction of Translational and Precision Medicine (TPM) efforts, using cutting-edge research to maximize the success of drug development programs in this key therapeutic area.
As the leader of the TPM team, you will oversee translational science, clinical biomarker development, and precision medicine studies. You will collaborate closely with discovery, preclinical, and clinical development teams to identify and advance new drug candidates efficiently through early and late-stage clinical trials.
This is a rare opportunity to help build and expand Teva’s presence in Immuno-oncology, contributing to the future of cancer treatment through innovative research and leadership.
How you’ll spend your day
Lead Drug Development Programs: Oversee TPM support for drug asset programs, enhancing success and de-risking development from first-in-human trials through post-approval.
Develop & Execute Strategy: Be accountable for the development and implementation of the TPM strategy for Immuno-oncology, aligning with Teva’s priorities.
Lead the TPM Immuno-oncology Disease Area Team: Manage a team of experts in Translational Science, Clinical Biomarkers, and Precision Medicine, ensuring regular reviews and strategic planning.
Biomarker Research Leadership: Lead initiatives in biomarker development, associating molecular, histologic, and digital biomarkers with drug response and safety.
Oversee Clinical Studies: Manage the design, execution, and interpretation of early-phase clinical studies, ensuring compliance with ethical, regulatory, and scientific standards.
Innovate Endpoints & Stratification: Oversee identification of novel clinical endpoints and patient stratification strategies to accelerate safety and efficacy demonstrations.
Collaborative Innovation: Partner with preclinical and clinical teams to expedite new drug candidates into late-stage development.
Regulatory Engagement: Lead regulatory submissions and interact with regulatory authorities, ensuring smooth approval processes.
Drive Scientific Insights: Oversee generation and application of clinical and scientific insights to optimize drug targeting, patient selection, and combination therapies.
External Leadership: Build collaborative relationships with academic institutions, patient groups, and commercial partners, and present research at international conferences.
